/Companies

Guard Therapeutics

8 employees on LinkedIn · 1 known investors

Find your way into Guard Therapeutics

Sign up to find every way you can get introduced to Guard Therapeutics

  • Your email: who you already know at Guard Therapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Guard Therapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Disruptive Pharma AB (formerly Guard Therapeutics International AB) is a pharmaceutical company listed on Nasdaq First North Growth Market under the ticker DPHA. The page contains shareholder and stock information but does not describe the company's products, therapeutic focus, or target markets.

Founders & leadership

TA
Tobias AgervaldCEO

Investors · 1

Funding

SEC filings, press & company announcements
  • Undisclosed amountRights OfferingApr 2025
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Guard Therapeutics do?
Disruptive Pharma AB (formerly Guard Therapeutics International AB) is a pharmaceutical company listed on Nasdaq First North Growth Market under the ticker DPHA. The page contains shareholder and stock information but does not describe the company's products, therapeutic focus, or target markets.
Who are Guard Therapeutics's investors?
Guard Therapeutics's investors include Industrifonden.